Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Treasury Shares (2016 - 2025)

BioCorRx's Treasury Shares history spans 13 years, with the latest figure at $1.2 million for Q3 2025.

  • For Q3 2025, Treasury Shares rose 2175.51% year-over-year to $1.2 million; the TTM value through Sep 2025 reached $1.2 million, up 2175.51%, while the annual FY2024 figure was $1.1 million, 39.35% down from the prior year.
  • Treasury Shares for Q3 2025 was $1.2 million at BioCorRx, down from $1.5 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.9 million in Q1 2025 and bottomed at $54474.0 in Q3 2024.
  • The 5-year median for Treasury Shares is $447797.0 (2022), against an average of $741833.9.
  • The largest annual shift saw Treasury Shares tumbled 86.13% in 2024 before it soared 2175.51% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $815351.0 in 2021, then crashed by 45.52% to $444167.0 in 2022, then surged by 297.57% to $1.8 million in 2023, then tumbled by 39.35% to $1.1 million in 2024, then grew by 15.75% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for BICX's Treasury Shares are $1.2 million (Q3 2025), $1.5 million (Q2 2025), and $1.9 million (Q1 2025).